Plasma total homocysteine level and its association with carotid intima-media thickness in obesity

Journal of Endocrinological Investigation

Volumn 28, Issue 1, 2005, Pages 928-934

  Uysal, O ^a   Arikan, E ^a   Cakir, B ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Carotid IMT; Homocysteine; Insulin resistance; Obesity

Indexed keywords

CREATININE; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHYROIDISM; INSULIN RESISTANCE; INTIMA; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OBESITY; PREGNANCY; SMOKING; ULTRASOUND; VITAMIN INTAKE;

EID: 31544473746     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345325     Document Type: Article

References (39)

1. Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 1996,93:1372-9.
2. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995,274:1049-57.
3. Ozkan Y, Ozkan E, Simsek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease, Int J Cardiol 2002,82:269-77.
4. Folsom AR. "New" risk factors for atherosclerotic diseases. Exp Gerontol 1999,34:483-90.
5. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 1998,158: 862-7.
6. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998,338:1042-50.
7. van Guldener C, Nanayakkara PW, Stehouwer CD. Homocysteine and blood pressure. Curr Hypertens Rep 2003,5: 26-31.
8. Splaver A, Lamas GA, Hennekens CH. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 2004,148:34-40.
9. van Guldener C, Stehouwer CD. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 2000,26:281-9.
10. Fonseca VA, Fink LM, Kern PA. Insulin sensitivity and plasma homocysteine concentrations in non-diabetic obese and normal weight subjects. Atherosclerosis 2003,167:105-9.
11. Konukoglu D, Serin O, Ercan M, Turhan MS. Plasma homocysteine levels in obese and non-obese subjects with or without hypertension; its relationship with oxidative stress and copper. Clin Biochem 2003,36:405-8.
12. El-Khairy L, Ueland PM, Nygard O, Refsum H, Vollset SE. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr 1999,70:1016-24.
13. Marchesini G, Manini R, Bianchi G, et al. Homocysteine and psychological traits: a study in obesity. Nutrition 2002,18: 403-7.
14. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999,340:14-22.
15. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997,96:1432-7.
16. Chambers JC, Obeid OA, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000,355: 523-7.
17. World Health Organization. Obesity. Preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, 3-5 June 1997. Geneva: World Health Organization 1998.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972,18:499-502.
19. Matthews DR, Connolly AA, Holman RR, Turner RC. Physiology of insulin secretion: problems of quantity and timing. Neth J Med 1985,28(Suppl 1):20-4.
20. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Comittee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997,20:1183-97.
21. Riley WA, Barnes RW, Applegate WB, et al. Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis. The Asymptomatic Carotid Artery Plaque Study. Stroke 1992,23:1062-8.
22. Gokcel A, Baltali M, Tarim E, et al. Detection of insulin resistance in Turkish adults: a hospital-based study. Diabetes Obes Metab 2003,5:126-30.
23. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001,73:613-21.
24. Panagiotakos DB, Pitsavos C, Zeimbekis A, Chrysohoou C, Stefanadis C. The association between lifestyle-related factors and plasma homocysteine levels in healthy individuals from the ATTICA Study, Int J Cardiol 2005,98:471-7.
25. Gomez-Ambrosi J, Salvador J, Paramo JA, et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem 2002, 35:315-20.
26. Reitman A, Friedrich I, Ben-Amotz A, Levy Y. Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity, Isr Med Assoc J 2002,4:590-3.
27. Nurk E, Tell GS, Vollset SE, et al. Changes in lifestyle and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 2004,79:812-9.
28. Sanchez-Margalet V, Valle M, Ruz FJ, Gascon F, Mateo J, Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 2002,13:75-9.
29. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998,139:197-8.
30. Oron-Herman M, Rosenthal T, Sela BA. Hyperhomocysteinemia as a component of syndrome X. Metabolism 2003,52:1491-5.
31. Godsland IF, Rosankiewicz JR, Proudler AJ, Johnston DG. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001,86: 719-23.
32. Abbasi F, Facchini F, Humphreys MH, Reaven GM. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 1999,146:175-8.
33. Bar-On H, Kidron M, Friedlander Y, et al. Plasma total homocysteine levels in subjects with hyperinsulinernia. J Intern Med 2000,247:287-94.
34. Rosolova H, Simon J, Mayer O Jr, Racek J, Dierze T, Jacobsen DW. Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res 2002,51:93-8.
35. Ganji V, Kafai MR. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2003,77: 826-33.
36. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995,274:1526-33.
37. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997,277:1775-81.
38. Kazmierski R, Watala C, Lukasik M, Kozubski W. Common carotid artery remodeling studied by sonomorphological criteria. J Neuroimaging 2004,14:258-64.
39. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000,72:315-23.